Nevin John

Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial

Jeremy Chataway, Floriana De Angelis, Peter Connick et al. · The Lancet Neurology · 2020 · 130 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

Disease-modifying therapies for multiple sclerosis

Floriana De Angelis, Nevin John, Wallace Brownlee · BMJ · 2018 · 102 citations · Full text

Medicine, Internal Medicine, Neurology +17

Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis

Izanne Roos, Stella Hughes, Gavin McDonnell et al. · JAMA Neurology · 2023 · 60 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +15

Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis

Peter Connick, Floriana De Angelis, Richard Parker et al. · BMJ Open · 2018 · 56 citations · Full text

Medicine, Neurology, Pharmacology +17

Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis

Tomáš Kalinčík, Sifat Sharmin, Izanne Roos et al. · JAMA Neurology · 2023 · 52 citations · Full text

Medicine, Neurology, Pharmacotherapy +13